Vaccine News and Research

Latest Vaccine News and Research

A new covid booster is here. Will those at greatest risk get it?

The Centers for Disease Control and Prevention recommends new covid-19 booster vaccines for all — but many who need them most won't get them. About 75% of people in the United States appear to have skipped last year's bivalent booster, and nothing suggests uptake will be better this time around.

15 Sep 2023

Phase 3 study: The efficacy of monovalent SARS-CoV-2 vaccine with AS03 adjuvant in adults

The effectiveness of a novel monovalent recombinant protein vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

15 Sep 2023

Past infections may shape your COVID booster's punch against Omicron

This in-depth study examines how previous immunity impacts the effectiveness of COVID-19 booster vaccinations and susceptibility to Omicron breakthrough infections. The research highlights the significant role of individual immune histories in shaping both humoral and cellular responses to SARS-CoV-2, urging for more tailored vaccine strategies.

14 Sep 2023

CDC awards $8.7 million to train and educate vector-borne disease professionals

To help respond to emerging and established vector-borne threats, the Northeast Regional Center for Excellence in Vector-Borne Diseases (NEVBD), led by Cornell, has received a five-year, $8.7 million award from the Centers for Disease Control and Prevention (CDC) to train and educate current and future vector-borne disease professionals and to evaluate the effectiveness of community and regional prevention strategies.

14 Sep 2023

UKHSA's flagship SIREN study enters new phase to continue surveillance of respiratory pathogens

The next phase of the study will be known as SIREN 2.0 and began in September 2023.

14 Sep 2023

A novel multi-epitope vaccine targeting extracellular proteins of Chlamydia pneumoniae

Researchers designed and evaluated a multi-epitope vaccine targeting the main outer membrane protein of Chlamydia pneumoniae using immunoinformatics.

14 Sep 2023

Results from a nested randomized controlled trial for BCG vaccination against recurrent herpes labialis

Researchers examined the effect of Bacillus Calmette-Guérin (BCG) vaccination on attenuating herpes labialis (cold sore) recurrences.

14 Sep 2023

Long COVID risk found to be significantly lower following Omicron infection

The risk of developing long COVID is significantly lower following an infection with the Omicron variant than after an infection with earlier coronavirus variants.

13 Sep 2023

Oral SARS-CoV-2 vaccine shows promise in monkeys

A new paper in Biology Methods and Protocols, published by Oxford University Press, indicates that researchers studying SARS-CoV-2 may have developed new methods to administer vaccines orally, which would be both easier to administer and more effective at combatting illnesses.

13 Sep 2023

Dormant HIV reservoirs can spontaneously produce RNA and proteins, study finds

HIV anti-retroviral therapy is considered a treatment and not a cure because patients usually carry a reservoir of HIV-infected cells that can re-emerge if treatment stops.

13 Sep 2023

Interferon-gamma essential for lung-resident memory B cell development after influenza infection

During a bout of influenza, B cells interact with other immune cells and then take different paths to defend the body.

13 Sep 2023

Researchers receive £2.66M to test new immunotherapeutic strategy for non-small cell lung cancer

University of Liverpool researchers have secured £2.66m Medical Research Council funding to clinically test a novel immunotherapeutic strategy for non-small cell lung cancer – one of the most deadly cancers.

13 Sep 2023

Why the CDC has recommended new covid boosters for all

Everyone over the age of 6 months should get the latest covid-19 booster, a federal expert panel recommended Tuesday after hearing an estimate that universal vaccination could prevent 100,000 more hospitalizations each year than if only the elderly were vaccinated.

13 Sep 2023

Immunity following vaccination provides better protection against COVID-19

A team from the UNIGE and the HUG analyzed the contacts of 50,000 COVID-19 positive cases. Immunity following vaccination provides better protection for those around you.

12 Sep 2023

Does IQ influence COVID-19 vaccination decision-making?

This study in the Journal of Health Economics finds that cognitive ability significantly influences the rate at which people get COVID-19 vaccinations. Pre-booked appointments were shown to effectively boost vaccination rates, especially among those with lower cognitive ability scores.

12 Sep 2023

Is the coadministration of a COVID-19 vaccine with a seasonal influenza vaccine safe and efficacious?

Researchers investigated the comparative efficacy and safety of the simultaneous COVID-19 and seasonal influenza vaccination regimen compared to SARS-CoV-2 vaccination alone among healthcare workers who had received one or two COVID-19 booster doses.

12 Sep 2023

“Inverse vaccine” shows promise to reverse autoimmune diseases without shutting down rest of the immune system

A new type of vaccine developed by researchers at the University of Chicago's Pritzker School of Molecular Engineering (PME) has shown in the lab setting that it can completely reverse autoimmune diseases like multiple sclerosis, type 1 diabetes, and Crohn's disease - all without shutting down the rest of the immune system.

12 Sep 2023

The safety and efficacy of the nano-based COVID-19 vaccine

Previous
1
...
56
57
58
59
60
61
62
...
1122
Next

Vaccine News and Research

Latest Vaccine News and Research

A new covid booster is here. Will those at greatest risk get it?

Phase 3 study: The efficacy of monovalent SARS-CoV-2 vaccine with AS03 adjuvant in adults

Past infections may shape your COVID booster's punch against Omicron

CDC awards $8.7 million to train and educate vector-borne disease professionals

UKHSA's flagship SIREN study enters new phase to continue surveillance of respiratory pathogens

A novel multi-epitope vaccine targeting extracellular proteins of Chlamydia pneumoniae

Results from a nested randomized controlled trial for BCG vaccination against recurrent herpes labialis

Long COVID risk found to be significantly lower following Omicron infection

Oral SARS-CoV-2 vaccine shows promise in monkeys

Dormant HIV reservoirs can spontaneously produce RNA and proteins, study finds

Interferon-gamma essential for lung-resident memory B cell development after influenza infection

Researchers receive £2.66M to test new immunotherapeutic strategy for non-small cell lung cancer

Why the CDC has recommended new covid boosters for all

Immunity following vaccination provides better protection against COVID-19

Does IQ influence COVID-19 vaccination decision-making?

Is the coadministration of a COVID-19 vaccine with a seasonal influenza vaccine safe and efficacious?

“Inverse vaccine” shows promise to reverse autoimmune diseases without shutting down rest of the immune system

The safety and efficacy of the nano-based COVID-19 vaccine

CDC recommendations for pneumococcal vaccine in adults

Oxford University study administers first-ever vaccine against Crimean-Congo hemorrhagic fever

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Vaccine News and Research

Latest Vaccine News and Research

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in